Results 101 to 110 of about 1,154,769 (315)

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

On the Issue of the Radon Activity of Tectonic Faults on the Qatar Peninsula

open access: yesNauka ta progres transportu
Purpose. The paper aims at providing the modern evaluation of radon activity in identified tectonic faults of the earth's crust based on archival data of radon measurements in groundwater which previously have been performed in the northern and eastern ...
V. Y. Ulyanov, V. V. Bilyk
doaj   +1 more source

Geothermal energy sources and possibilities of their exploitation [PDF]

open access: yesActa Montanistica Slovaca, 2007
The geothermal energy is everywhere beneath the surface of the earth. The earth’s interior is enormous thermal reservoir of energy, which can be utilized if favorable geological conditions exist.The electricity generation in 1942 at Larderello was a ...
Pavol Rybár
doaj  

Therapeutic Apheresis for Intravenous Methylprednisolone‐Refractory Neuromyelitis Optica Spectrum Disorder: Clinical and Radiological Outcomes in a Single‐Center Case Series

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system. High‐dose intravenous methylprednisolone (IVMP) is the standard first‐line therapy for acute attacks, although some patients remain refractory.
Wataru Horiguchi   +5 more
wiley   +1 more source

Effects of the Fluid Replacement Method During Online Hemodiafiltration on the Solute Removal Performance and Biocompatibility Using the Asymmetric Cellulose Triacetate Membrane

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Pre‐dilution online hemodiafiltration (Pre‐HDF) is predominantly used in Japan, whereas post‐dilution online HDF (Post‐HDF) is more common in Europe. An asymmetric cellulose triacetate (ATA) membrane may improve biocompatibility.
Kenji Sakurai   +4 more
wiley   +1 more source

Well testing/Well Design in CBM wells

open access: yes71st EAGE Conference and Exhibition - Workshops and Fieldtrips, 2009
There are a number of completion options available for successful development of CBM. A number of design factors, with field examples, will be presented in this paper as follows: • a comparison of the performance of horizontal wells with vertical wells; covering the effects of wellbore length, skin factor and coal seam thickness on performance.
openaire   +2 more sources

Infection Control Practices for Vascular Access Management in Hemodialysis: Results From a Nationwide Survey of Japanese National University Hospitals

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Bloodstream infections due to repeated vascular access (VA) puncture and circuit connections remain major concerns in hemodialysis. Therefore, we examined current practices for glove, disinfectant, and personal protective equipment (PPE) use according to VA type in national university hospitals in Japan.
Aiko Yamada   +6 more
wiley   +1 more source

A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy